This track focuses on the latest advancements in immunoengineering, emphasizing novel approaches to manipulate the immune system for therapeutic purposes. Researchers are encouraged to present their findings on engineered immune cells and biomaterials that enhance immune responses.

This session will explore cutting-edge technologies in vaccine design, including mRNA platforms, viral vectors, and nanoparticle-based delivery systems. Contributions that highlight the integration of computational modeling in vaccine development are particularly welcome.

This track aims to discuss computational and mathematical models that simulate immune system dynamics and responses. Presentations should focus on the implications of these models for predicting outcomes in immunotherapy and vaccine efficacy.

This session will highlight the role of biomedical engineering in the design and production of vaccines. Topics may include bioprocess engineering, formulation strategies, and quality control measures that enhance vaccine safety and effectiveness.

This track will delve into the use of synthetic biology techniques to engineer immune cells and create novel immunotherapeutics. Researchers are invited to share their insights on gene editing, synthetic circuits, and their applications in combating diseases.

This session will focus on methodologies for optimizing drug development processes, particularly in the context of immunotherapeutics. Contributions that address system biology approaches and high-throughput screening techniques are encouraged.